GEBT Telehealth Administration Usability Study

Status Completed

Clinical Trial Summary

The purpose of this study is to establish the usability of a telehealth platform for the administration of GEBT.

Clinical Trial Description

This study is intended to demonstrate that the 13C-Spirulina Gastric Emptying Breath Test (GEBT) can be successfully administered via a telehealth platform. Telehealth administration of GEBT is where a trained Cairn employee uses a video link to remotely supervise the completion of the test request form, collection of breath samples, cooking and consumption of the test meal and return of breath samples by the patient to Cairn. ;

Study Design

Related Conditions & MeSH terms

Gastroparesis

Clinical Trial Details

NCT number	NCT04684992
Study type	Interventional
Source	Cairn Diagnostics
Contact
Status	Completed
Phase	N/A
Start date	December 11, 2020
Completion date	March 10, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03941288` - Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia	Phase 2
Terminated	`NCT03285308` - A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01	Phase 3
Completed	`NCT00733551` - Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.	Phase 1
Completed	`NCT01650714` - Endoscopic Full Thickness Biopsy, Gastric Wall.	N/A
Completed	`NCT01452815` - Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis	Phase 2
Completed	`NCT01039974` - GSK962040 Drug-drug Interaction Study With Ketoconazole	Phase 1
Terminated	`NCT04844190` - Use of EndoFLIP and Manometry Prior to G-POEM	N/A
Enrolling by invitation	`NCT06215547` - Medtronic Enterra II Neurostimulator	N/A
Completed	`NCT04026997` - A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis	Phase 2
Completed	`NCT00562848` - A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040	Phase 1
Enrolling by invitation	`NCT04207996` - Vagus Nerve Response in Gastroparesis Patients
Completed	`NCT04607304` - ABCA2 GIRMS Analytical Validation Clinical Performance Study	N/A
Recruiting	`NCT06068114` - Gastric Pathophysiology in Diabetes
Completed	`NCT03259841` - Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy
Active, not recruiting	`NCT04300127` - Pioglitazone for Idiopathic Gastroparesis	Early Phase 1
Recruiting	`NCT01696734` - Domperidone in Treating Patients With Gastrointestinal Disorders	Phase 3
Terminated	`NCT04635306` - 13C-Spirulina Nitrogen Content GEBT Study	N/A
Withdrawn	`NCT02420925` - Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis	N/A
Recruiting	`NCT00777439` - Domperidone for Refractory Gastrointestinal Disorders	N/A
Terminated	`NCT00760461` - Domperidone in Refractory Gastroparesis	Phase 2